Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

The Effect of Care Protocol on the Outcomes of Patients With Lung Surgery

23 juli 2021 uppdaterad av: Dilara Soydan, Mersin University

Improving Pulmonary Function The Effect of Care Protocol on the Outcomes of Patients With Thoracotomy

This randomized controlled trial evaluates the effect of the care protocol, which consists of independent nursing interventions, which play an important role in accelerating the recovery process of the patient, such as the patient's position, mobilization, use of spirometry, and providing shoulder exercises after thoracotomy. The hypothesis of this research is; the care protocol applied to the patients after thoracotomy has an effect on the patients' pulmonary function tests (FVC, FEV1, FEV1/FVC) and on the mobilization of the patients, the development of complications, the time of chest tube removal and the discharge

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Intervention / Behandling

Detaljerad beskrivning

Methods: In the study, 80 patients were randomly assigned to the study and control groups. Nursing interventions will be applied to the patients included in the study group (n=40), starting from the 0th day (the first day spent in the intensive care unit) after the thoracotomy in line with the prepared care protocol application steps until discharge. maintenance protocol; It will consist of position of the patient, mobilization, use of spirometer and shoulder exercises. The primary outcome of the research is the effect of the maintenance protocol used in the improvement of respiratory function on respiratory function tests. The secondary outcome of the research is to determine the effect of the care protocol on mobilization, complication development status, chest tube removal and discharge time in patients. The results are obtained by recording PFT values on the 1st, 5th and discharge days before and after thoracotomy. Postoperative (0.,1.,2.,3.,4.,5.) days and discharge day; mobilization, complication development status, chest tube removal time and discharge date will be recorded on the Patient Results Form.

Studietyp

Interventionell

Inskrivning (Förväntat)

80

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 80 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Accepting to participate in the research,
  • 18 years and older,
  • Conscious, oriented and cooperative,
  • Able to speak and understand Turkish,
  • Does not have any psychiatric disease,
  • Elective thoracotomy performed,
  • Chest tube inserted,
  • Patients who were followed up in the intensive care unit on the first day after surgery and admitted to the clinic the next day
  • Patients without a history of metastatic disease

Exclusion Criteria:

  • Those who do not accepted to participate in the research,
  • Under 18 years of age,
  • Unconscious, without orientation and cooperation,
  • Who cannot speak or understand Turkish,
  • Having a psychiatric problem,
  • Non thoracotomy
  • Non chest tube,
  • Metastatic disease,
  • Emergency thoracotomy applied,
  • Patients staying in the intensive care unit for more than one day.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Inget ingripande: Control group
In the control group (n=40), interventions for the position, mobilization and spirometry of the patient are applied to all patients in the clinic where the study was conducted. However, these applications are not made in accordance with a certain order and protocol. Shoulder exercises are not routinely taught to patients. In the study, no additional application will be made to the control group other than the routine treatment and care practice of the clinic.
Experimentell: Intervention
Care protocol will be applied to the study group (n=40), starting from the first day spent in the intensive care unit.Care protocol consists of patient's position, mobilization, use of spirometer and shoulder exercises. The bed head of the patient will be raised 30°-45° in line with the application steps. In the study, the patient's in-bed and out-of-bed mobilization will be provided by considering the mobilization application steps, and the patient will be asked to stay out of bed for two hours on the 0 th day after surgery. The patient will be asked to stay out of bed for six hours from the first postoperative day until discharge. After the thoracotomy, the conditions that the doctor considers as complications will be recorded.The time of chest tube removal and the day of discharge will be recorded. In the study, the use of spirometry and shoulder exercises will be carried out by taking into account the implementation steps of the care protocol.
Övrig: Care protocol

Before starting the application, the investigator (DS) will fill out the Introductory Characteristics Form of all patients, the Pre-thoracotomy Pulmonary Function Test (PFT) section of the Patient Results Form. The PFT section will be re-evaluated on the 1st, 5th day and on the day of discharge after thoracotomy.

Nursing interventions will be applied to the study group (n=40), starting from the 0th day (the first day spent in the intensive care unit) after the thoracotomy in line with the prepared care protocol application steps until discharge. Care protocol consists of patient's position, mobilization, use of spirometer and shoulder exercises.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Pulmonary function test values evaluated using the care protocol
Tidsram: Change from before implementation preoperative and postoperative (1.,5.) days and an average of 2 weeks
Pulmonary function tests. Pulmonary function tests will be measured with a portable pulmonary function tester. In the evaluation, FVC (%), FEV1 (%) and FEV1/FVC (%) parameters will be used
Change from before implementation preoperative and postoperative (1.,5.) days and an average of 2 weeks

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mobilization evaluated using the care protocol
Tidsram: Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
In the study, the patient's in-bed and out-of-bed mobilization will be provided by considering the mobilization application steps, and the patient will be asked to stay out of bed for two hours on the 0 th day after surgery. In the clinic, the patient will be mobilized in line with the mobilization application steps. The patient will be asked to stay out of bed for six hours from the first postoperative day until discharge. The steps taken will be recorded with the pedometer
Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Prevention of complications evaluated using the care protocol
Tidsram: Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
After the thoracotomy, the conditions that the doctor considers as complications (atelectasis, pneumonia, air leak, bronchospasm, subcutaneous emphysema, atrial fibrillation) will be recorded and daily evaluation will be made.
Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Chest tube removal evaluated using the care protocol
Tidsram: Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
The time of chest tube removal and the day will be recorded in the Patient Results Form
Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
Discharge time evaluated using the care protocol
Tidsram: Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks
The time of discharge will be recorded in the Patient Results Form
Change from before implementation and postoperative (0.,1.,2.,3.,4.,5.) days and an average of 2 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Mersin University

Utredare

  • Studierektor: GÜLAY ALTUN UĞRAŞ, Doctorate, Researcher

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Förväntat)

28 augusti 2021

Primärt slutförande (Förväntat)

28 augusti 2022

Avslutad studie (Förväntat)

30 december 2022

Studieregistreringsdatum

Först inskickad

7 juli 2021

Först inskickad som uppfyllde QC-kriterierna

23 juli 2021

Första postat (Faktisk)

27 juli 2021

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

27 juli 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

23 juli 2021

Senast verifierad

1 juli 2021

Mer information

Termer relaterade till denna studie

Nyckelord

Andra studie-ID-nummer

  • MersinUniversityNursingFaculty

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Patientresultat

Kliniska prövningar på Care protocol

Sök liknande försök

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

CROs by country

CROs in Macedonia

Betingelser

Sällsynta sjukdomar

Läkemedelsinterventioner

Kosttillskott

Sponsor / medarbetare

Platser

3
Prenumerera